Immunovant

Immunovant

Biotechnology Research

Dedicated to enabling normal lives for people with autoimmune diseases

About us

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. For U.S. residents only.

Website
https://www.immunovant.com/join-us/values-culture
Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
New York
Type
Public Company
Founded
2018
Specialties
Autoimmune disease

Locations

Employees at Immunovant

Updates

Similar pages

Browse jobs

Funding

Immunovant 4 total rounds

Last Round

Post IPO equity

US$ 450.0M

See more info on crunchbase